相关实验视频
Updated: Jun 14, 2025

09:36
Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
290
社会脆弱性和国家糖尿病预防计划认可状态
Taynara Formagini1, Daphnee Rodriguez2, Ariba Rezwan3
1Department of Family Medicine, University of California San Diego, San Diego, California; School of Social Work, University of Central Florida, Orlando, Florida.
American journal of preventive medicine
|September 1, 2024
概括
社会脆弱性较高的县面临着更大的可能性,没有在国家糖尿病预防计划 (国家DPP) 中得到充分认可的组织. 这凸显了需要解决方案公平性和可持续性的差异.
科学领域:
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
- 预防糖尿病 预防糖尿病
背景情况:
- 国家糖尿病预防计划 (National DPP) 旨在减少美国的2型糖尿病发病率.
- 组织需要为计划的可持续性和退款提供全额/全额加分认可.
- 处境不利的地区可能会面临实现充分承认的障碍.
研究的目的:
- 检查县级社会脆弱性与国家DPP全额/全额+认可状态之间的关联.
- 根据社会脆弱性,识别基于计划认可的潜在差异.
主要方法:
- 利用了2022年国家DPP注册表和2018年CDC社会脆弱性指数 (SVI).
- 为县的认可状态创建了一个三级分类变量 (n=843).
- 采用多项逻辑模型来分析SVI与认可之间的关联,调整混因素.
主要成果:
- 更高的社会脆弱性与更大可能没有拥有完全/完全加分认可的组织的可能性显著相关.
- 高SVI的县有2.63倍更高的机会没有完全认可的组织,与那些有所有完全认可的组织相比.
结论:
- 调查结果表明,在脆弱社区的国家DPP认可状况中存在差异.
- 需要制定战略来支持高SVI地区的组织实现充分认可.
- 解决这些差异对于计划的可持续性和减少糖尿病健康不平等至关重要.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
520
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Pathophysiology of Diabetes
908
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
908
Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178

